Quarterly Result12 Aug 2026, 02:40 pm
Shukra Pharmaceuticals declares Q1 FY27 Un-Audited Results
AI Summary
Shukra Pharmaceuticals Ltd announced its un-audited financial results for the first quarter ended June 30, 2026. The Board of Directors approved these results along with the Auditors' Limited Review Report. The financial statements were reviewed by the Audit Committee and audited by M/s Shah Sanghvi and Associates. The company reported its standalone and consolidated financial results for the period. No investor complaints were received during the quarter.
Key Highlights
- Board approved un-audited financial results for Q1 FY27.
- Results reviewed by Audit Committee and statutory auditors.
- Standalone and consolidated results declared.
- No investor complaints received during the quarter.
Price Impact
More from SHUKRAPHAR
More in Quarterly Result